Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Immune modulation via cutaneous stimulation" refers to the regulation of the immune response through sensory or physical stimulation of the skin. This process involves complex interactions between skin-resident immune cells (such as dendritic cells, mast cells, and T cells) and sensory nerves. Stimulation of cutaneous sensory fibers can lead to the release of neuropeptides (such as calcitonin gene-related peptide and substance P), which modulate the function of local immune cells, orchestrate inflammation, and influence disease processes such as infection, allergy, autoimmunity, wound healing, and cancer. This is a physiological process, not a distinct molecular entity, and encompasses diverse signaling pathways and cell types.
Stimulation of skin sensory nerves can modulate cytokine production, immune cell migration, and inflammatory signaling via neuropeptide release (e.g., CGRP, substance P).\nElectrical or physical stimulation (e.g., transcutaneous electrical nerve stimulation) may indirectly alter immune responses via neural-immune pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune modulation via cutaneous stimulation.